RxDoctor Payments Data

Jeremy Derickson, PA

Physician Assistant · Mesa, AZNPI 1821544503

Payments from drug & device makers

$6,973in general payments, 2019–2025

Across 383 payments — averaging $18.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • AstraZeneca$924
  • GSK$631
  • Lilly USA, LLC$461
  • Boehringer Ingelheim$428
  • Abbott$311
  • plus $3K from 42 others

What the payments were for

  • Food & beverage$6,959100%
  • Entertainment$150%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,973 in reported general payments places this provider in the 90th percentile of 2,888 physician assistant providers in Arizona.

See all physician assistant providers in Arizona

Medicare billing

Part B allowed, 2024
$59,987
Medicare patients
228
Services billed
815

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin60$63,076
OzempicSemaglutide30$46,542
TrulicityDulaglutide25$40,216
EliquisApixaban27$33,672
ProliaDenosumab15$26,317
XareltoRivaroxaban14$21,834
MounjaroTirzepatide16$18,231
JanuviaSitagliptin Phosphate15$17,101
Tresiba Flextouch U-200Insulin Degludec11$16,001
Atorvastatin Calcium314$2,474
Albuterol Sulfate HfaAlbuterol Sulfate74$2,148
Lantus SolostarInsulin Glargine,hum.Rec.Anlog15$2,120
Tamsulosin Hcl127$2,085
Rosuvastatin Calcium110$1,777
Levothyroxine Sodium227$1,777

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$428$63,07660 claims
Lilly USA, LLCTrulicity, Mounjaro$461$58,44741 claims
Novo NordiskOzempic$1,108$46,54230 claims
PfizerEliquis$98$33,67227 claims
AmgenProlia$122$26,31715 claims
Johnson & JohnsonXarelto$144$21,83414 claims
MerckJanuvia$162$17,10115 claims
AbbVieSynthroid$301$1,13218 claims
Sanofi-aventis U.S. LLCLantus$38$96412 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,888 physician assistant providers in Arizona.

Other physician assistant in Mesa

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →